Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 4Recruiting 4Not yet recruiting 3Withdrawn 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Lymphoma, B-Cell 2Recurrence 1Lymphoma, Follicular 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Carboplatin 127Cisplatin 125Drug Therapy 116Bevacizumab 102Capecitabine 100Oxaliplatin 99Radiotherapy 97Gemcitabine 87tislelizumab 86Paclitaxel 86Cyclophosphamide 85pembrolizumab 77Specimen Handling 77toripalimab 70Magnetic Resonance Spectroscopy 63Injections 63Fluorouracil 63sintilimab 58Surgical Procedures, Operative 58anlotinib 53Docetaxel 52130-nm albumin-bound paclitaxel 51fludarabine 47Standard of Care 45Pemetrexed 45Immune Checkpoint Inhibitors 45Blood Specimen Collection 43venetoclax 42Leucovorin 42lenvatinib 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × relmacabtagene autoleucel × Clear all
NCT07326371 2026-01-08

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

Ruijin Hospital

Phase 2 Not yet recruiting
24 enrolled
Sarcoma

Dendritic Cell Sarcoma, Interdigitating

NCT06142188 2023-11-21

Relmacabtagene Autoleucel in Hematologic Malignancies

Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting
150 enrolled
Lymphoid

Lymphoma, Follicular, Lymphoma, B-Cell

NCT05814848 2023-06-15

A Study of Secondary Infusion of Relmacabtagene Autoleucel Injection for Relapsed or Refractory B-cell Lymphoma

Changhai Hospital

Phase 4 Not yet recruiting
13 enrolled
Lymphoid

Recurrence, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡